Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Angiotensin II type 1 receptor blocker
Welcome,
Profile
Billing
Logout
Companies
Products
Products
Diseases
Trials
News
«
1
2
3
||
||||||||
Enrollment closed, Adherence:
Impact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk Patients
(clinicaltrials.gov) - Feb 4, 2014
P=N/A
, N=2000, Active, not recruiting,
Sponsor: Boehringer Ingelheim
Recruiting --> Active, not recruiting